IgCares – Infusion Support 17+

Simplified treatment management, education, and patient support in the palm of your hand. Track infusion details and health, support the PI community and more.

Please see the IgCares™ app information below.

THROMBOSIS MAY OCCUR WITH IMMUNE GLOBULIN PRODUCTS, INCLUDING CUTAQUIG (IMMUNE GLOBULIN SUBCUTANEOUS [HUMAN]-HIPP, 16.5% SOLUTION).

RISK FACTORS MAY INCLUDE: ADVANCED AGE, PROLONGED IMMOBILIZATION, HYPERCOAGULABLE CONDITIONS, HISTORY OF VENOUS OR ARTERIAL THROMBOSIS, USE OF ESTROGENS, INDWELLING VASCULAR CATHETERS, HYPERVISCOSITY, AND CARDIOVASCULAR RISK FACTORS.

FOR PATIENTS AT RISK OF THROMBOSIS, ADMINISTER CUTAQUIG AT THE MINIMUM DOSE AND INFUSION RATE PRACTICABLE. ENSURE ADEQUATE HYDRATION IN PATIENTS BEFORE ADMINISTRATION. MONITOR FOR SIGNS AND SYMPTOMS OF THROMBOSIS AND ASSESS BLOOD VISCOSITY IN PATIENTS AT RISK OF HYPERVISCOSITY.
----------

The IgCares app provides on-demand support for patients with primary immunodeficiency (PI) and their caregivers. Including tools to simplify treatment management, educational materials, and access to other patient resources such as Nurse Advisor support and the IgCares recycling program, it has everything you need to stay on top of your care.*

PI TREATMENT MANAGEMENT
• Treatment details: Track details about your treatment regimen such as infusion schedule, dose, volume, and pump information.
• Infusion tracking: Keep a record of the important aspects of your infusions including duration, sites used, product details, and notes.
• Vial scanning: Use the app to record details from the vials used during your infusions (available on devices running iOS 13 or newer).
• Side effects tracking: Record side effects experienced such as local site reactions or systemic reactions. Take photos of any relevant reactions.
• Health tracking: Keep a record of health indicators as it relates to your condition, including illness, IgG levels, pain, and fatigue.
• Automated reminders: Set notifications for scheduled or missed infusions and prescription refills.

EDUCATIONAL CONTENT
The app has materials covering a range of topics, including info about PI, managing treatment, and lifestyle tips for PI patients. Examples include:
• Self-Infusion: What to Expect
• SCIg Infusion and Troubleshooting Guides
• Guide for Speaking with Your Insurance Provider
• Managing Side Effects

INSURANCE BENEFITS SUPPORT & CO-PAY ASSISTANCE
Contact the IgCares Support Center from the app to speak to a Program Specialist about insurance benefits and co-pay assistance.* Co-pay assistance is for eligible patients on an Octapharma SCIg treatment.

NURSE SUPPORT
Also available via the Support Center are registered nurses who can inform you on what to expect in regards to your treatment and address concerns regarding potential treatment issues.*

INFUSION MATERIALS RECYCLING PROGRAM
IgCares offers a recycling program for patients on an Octapharma SCIg treatment. The program transforms infusion supplies and the associated packaging materials into energy. Enroll in the program right from the app. It’s all a part of Octapharma’s commitment to your health and the health of our planet.*

CHARITABLE GIVING INITIATIVE
The IgCares charitable giving initiative is designed to donate funds in support of the PI community. Every time you participate in program point activities — such as logging infusions or consuming educational content — you’ll earn donation points to be contributed to the participating charity you choose. Every point you earn is a dollar Octapharma will donate.

IgCares is a comprehensive PI support program from Octapharma. It provides education and treatment resources to PI patients and caregivers and benefits the PI community at large.

Please see full prescribing information and important safety information for cutaquig (Immune Globulin Subcutaneous [Human]– hipp, 16.5% solution), including boxed warning at www.cutaquigusa.com.

*Certain components of the IgCares program are available only for patients who are using or have a prescription for an Octapharma subcutaneous immunoglobulin product for the treatment of primary immunodeficiency, or their caregivers.